(Q38010304)

26 August 2017

title

The mTOR pathway in lung cancer and implications for therapy and biomarker analysis (English)

1 reference

26 August 2017

0 references

1 reference

3

Fred R Hirsch

1 reference

26 August 2017

Simon Ekman

1

1 reference

26 August 2017

Murry W Wynes

series ordinal

2

1 reference

26 August 2017

publication date

1 June 2012

1 reference

Journal of Thoracic Oncology

26 August 2017

published in

1 reference

26 August 2017

volume

7

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

947-953

1 reference

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

26 August 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1200/JCO.2008.19.9331

Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab

1 reference

https://opencitations.net/index/api/v1/citations/10.1038/SJ.BJC.6605972

COCI

reference URL

10.1097/JTO.0B013E31825581BD

9 February 2024

Identifiers

DOI

1 reference

26 August 2017

1 reference